Cardio Diagnostics Holdings, Inc.: Form 10-Q for the period ended Sep 30, 2022
Filed with the SEC on Nov 7, 2022 and accepted by EDGAR at Nov 7, 2022, 16:13 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2022-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Operating income | 3 months2022-07-01 to 2022-09-30 | −$165.3k | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2022-01-01 to 2022-09-30 | −$891.0k | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2022-07-01 to 2022-09-30 | $0 | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2022-01-01 to 2022-09-30 | $0 | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2022-07-01 to 2022-09-30 | $202.3k | us-gaap:NetIncomeLoss |
| Net income | 9 months2022-01-01 to 2022-09-30 | −$513.0k | us-gaap:NetIncomeLoss |
| Operating cash flow | 9 months2022-01-01 to 2022-09-30 | −$587.0k | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Cash and equivalents | At period end2022-09-30 | $0 | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2022-09-30 | $228.1k | us-gaap:AssetsCurrent |
| Total assets | At period end2022-09-30 | $65.8m | us-gaap:Assets |
| Current liabilities | At period end2022-09-30 | $631.7k | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2022-09-30 | $631.7k | us-gaap:Liabilities |
| Shareholders' equity | At period end2022-09-30 | −$353.7k | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001079973-22-001398. Last ingested by Listed: Nov 6, 2026, 12:11 ET. Listed shows no prices and gives no investment advice.